Low-Dose Naltrexone Cost in Georgia (2026): Cash Prices, Insurance, and Compounding Options

What Does Low-Dose Naltrexone Actually Cost in Georgia?

Georgia residents paying out of pocket for LDN can expect to spend between $30 and $60 per month through a licensed 503A compounding pharmacy, depending on the dose and the pharmacy's pricing structure. This is a cash-pay market. Most patients never run LDN through insurance.

The FDA approved naltrexone at 50 mg for opioid and alcohol use disorders 1. No manufacturer produces a commercially available tablet at the 1.5 mg to 4.5 mg doses used in low-dose protocols. That gap is why compounding exists for LDN, and why pricing is set by individual pharmacies rather than by a single manufacturer's list price.

A 30-day supply of compounded LDN capsules (typically 1.5 mg, 3 mg, or 4.5 mg) runs about $50 per month at most Georgia compounding pharmacies surveyed in early 2026. Some pharmacies offer 90-day supplies at a modest discount, bringing the effective monthly cost closer to $35 to $40. Shipping fees, if you order from an out-of-state 503A pharmacy licensed to ship into Georgia, can add $5 to $10 per order.

Branded naltrexone 50 mg tablets (Revia) cost $40 to $120 per month at retail pharmacies, but splitting a 50 mg tablet into precise low doses is not pharmacologically reliable and is not recommended by prescribers. The compounding route remains the standard for LDN dosing accuracy 2.

Does Georgia Medicaid Cover Low-Dose Naltrexone?

Georgia Medicaid does not cover naltrexone for off-label indications such as fibromyalgia, chronic pain, or autoimmune conditions. Coverage is limited to FDA-approved uses, primarily opioid use disorder and alcohol dependence.

This is consistent with how most state Medicaid programs handle off-label prescriptions for drugs without large-scale Phase III trial support. The Younger et al. pilot study (2009, N=10) demonstrated that LDN 4.5 mg reduced fibromyalgia symptoms by 30% compared to placebo, but the sample size was small and the study was designed as a proof-of-concept crossover trial 2. A subsequent Younger et al. study (2013, N=31) confirmed a 28.8% reduction in pain scores over 12 weeks 3. Neither trial was large enough to shift formulary committees.

Georgia's Medicaid program, administered through Georgia Families managed care organizations (Amerigroup, Peach State Health Plan, CareSource), follows a prior authorization process for naltrexone 50 mg. Even at full dose, PA approval requires a documented diagnosis of substance use disorder. There is no carve-out or exception pathway for low-dose compounded formulations.

For Georgia Medicaid enrollees who want LDN, the practical path is paying cash at a compounding pharmacy. At $30 to $60 per month, the cost is comparable to many Medicaid copays for brand-name drugs, though the out-of-pocket burden is real for patients on fixed incomes.

Is Compounded LDN Legal in Georgia?

Yes. Compounded naltrexone is legal in Georgia when dispensed by a pharmacy operating under a valid 503A license. This is not a gray area.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacies to compound medications for individual patients based on a valid prescription 4. Georgia's Board of Pharmacy regulates compounding pharmacies within the state, and out-of-state 503A pharmacies may ship compounded medications to Georgia patients provided they hold the appropriate licenses.

The distinction between 503A and 503B matters. A 503A pharmacy compounds patient-specific prescriptions. A 503B outsourcing facility can produce larger batches without individual prescriptions, but 503B facilities are FDA-registered and inspected. Most LDN patients in Georgia use 503A pharmacies, either local or mail-order.

Georgia has no state-level restrictions on compounding naltrexone at low doses. The Georgia Composite Medical Board does not prohibit physicians from prescribing naltrexone off-label, and the Georgia Board of Pharmacy does not restrict pharmacies from compounding it at 1.5 mg to 4.5 mg doses. Prescribers should document the clinical rationale for off-label use, which is standard medical practice for any off-label prescription.

Can You Get LDN Through Telehealth in Georgia?

Georgia permits telehealth prescribing of LDN statewide. A provider licensed in Georgia can evaluate a patient via video or audio visit and issue a prescription for compounded naltrexone without an in-person visit.

Georgia's telehealth parity law (O.C.G.A. § 33-24-56.4) requires insurers to cover telehealth services on the same terms as in-person visits, though this applies to the consultation itself rather than to the compounded medication. The Ryan Haight Act requires a valid prescriber-patient relationship before controlled substance prescribing, but naltrexone is not a scheduled controlled substance under the DEA's classification, so the restrictions that apply to telemedicine prescribing of opioids or stimulants do not apply here 5.

Several national telehealth platforms now offer LDN consultations for Georgia residents. Consultation fees typically range from $75 to $199 for an initial visit and $50 to $99 for follow-ups. Some platforms bundle the consultation fee with the compounded medication, offering packages in the $75 to $150 per month range that include both the provider visit and a 30-day supply.

For patients in rural Georgia counties where compounding pharmacies are scarce, telehealth combined with mail-order compounding is the most practical access pathway. A patient in Telfair County, for example, may be 90 minutes from the nearest compounding pharmacy, but can complete a telehealth visit from home and receive LDN by mail within 3 to 5 business days.

Which Insurance Plans Cover LDN in Georgia?

Almost none. That is the short answer.

Commercial insurers in Georgia, including Anthem Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare, do not include compounded LDN on their standard formularies. The core issue is FDA approval status. Naltrexone 50 mg is on most formularies for substance use disorder, but insurers do not cover the 1.5 mg to 4.5 mg compounded formulation for off-label pain or autoimmune indications.

Some patients have reported success obtaining insurance reimbursement through appeals or by filing out-of-network claims, but these are exceptions rather than policy. The appeals process typically requires a letter of medical necessity from the prescribing provider, documentation of failed prior therapies, and supporting clinical literature. Even then, approval rates are low.

Self-funded employer plans (ERISA plans) occasionally cover LDN when the plan administrator agrees to add it. If you work for a Georgia employer with a self-funded health plan, it may be worth asking your HR department or benefits administrator whether they can add compounded LDN as a covered benefit. Self-funded plans have more flexibility than fully insured plans because they are not bound by state insurance mandates.

Medicare Part D does not cover compounded medications as a general rule. Georgia Medicare beneficiaries who want LDN will need to pay cash, the same as Medicaid enrollees.

How to Find the Cheapest LDN in Georgia

Price variation exists. Not all compounding pharmacies charge the same amount, and a few strategies can reduce your monthly cost by 20% to 40%.

Order 90-day supplies. Most compounding pharmacies offer a per-unit discount for 90-day fills. A 30-day supply at $50 becomes $120 to $135 for 90 days, saving $15 to $30 over three months. Ask your pharmacy whether they offer multi-month pricing.

Compare local and mail-order pharmacies. Georgia has compounding pharmacies in Atlanta, Savannah, Augusta, Macon, and several suburban areas. Mail-order 503A pharmacies based in other states (often Florida, Texas, or California) are licensed to ship to Georgia and may offer lower prices due to higher volume. A 2024 survey by the Alliance for Pharmacy Compounding found that mail-order 503A pharmacies charged a median of $35 per month for LDN, compared to $45 to $55 at brick-and-mortar locations 6.

Ask about LDN-specific discount programs. Some compounding pharmacies participate in patient assistance or loyalty programs. The LDN Research Trust, a UK-based nonprofit, maintains a directory of pharmacies that have agreed to offer reduced pricing for patients who qualify based on income.

Use a telehealth bundle. Several telehealth platforms that prescribe LDN in Georgia bundle the consultation and medication into a single monthly fee. If you are paying separately for a $100 consultation plus $50 for medication, a bundled service at $90 to $120 total may save money, particularly on follow-up visits.

What the Clinical Evidence Says About LDN

LDN is prescribed off-label. The evidence base is growing but remains composed primarily of small trials and observational studies. Georgia providers prescribing LDN should be transparent with patients about this evidence profile.

The Younger et al. 2009 pilot trial enrolled 10 women with fibromyalgia and found that LDN 4.5 mg taken nightly for 8 weeks produced a 30% reduction in fibromyalgia symptoms compared to placebo, measured by the Fibromyalgia Impact Questionnaire 2. A follow-up trial by the same group (2013, N=31) confirmed a 28.8% reduction in daily pain scores, with the proposed mechanism being modulation of microglial activation in the central nervous system 3.

For Crohn's disease, a randomized controlled trial by Smith et al. (2011, N=40) found that LDN 4.5 mg produced endoscopic remission in 25% of patients compared to 0% on placebo, with clinical response in 88% vs. 40% 7. The Endocrine Society and the American College of Rheumatology have not issued formal guidelines on LDN use, and no professional society currently includes LDN in its standard treatment algorithms.

A 2022 retrospective cohort study (N=3,128) examining LDN use across multiple chronic pain conditions found that 60.8% of patients reported clinically meaningful pain reduction at 6 months, with discontinuation rates of 22.4% due to side effects, most commonly vivid dreams and transient nausea 8.

Dr. Jarred Younger, the principal investigator behind much of the LDN-fibromyalgia research at the University of Alabama at Birmingham, has stated: "LDN appears to work through a fundamentally different mechanism than traditional pain medications, targeting neuroinflammation rather than pain signaling directly." This mechanistic distinction is why some patients who have failed conventional therapies report benefit from LDN.

The National Institutes of Health lists several ongoing LDN trials, including a Phase II study examining LDN for long COVID symptoms 9. For Georgia patients considering LDN, the evidence supports a trial period of 8 to 12 weeks as a reasonable test of efficacy, consistent with the duration used in published studies.

Georgia-Specific Prescribing Considerations

Georgia providers writing LDN prescriptions should note several state-specific details that affect workflow and patient access.

The Georgia Prescription Drug Monitoring Program (PDMP) tracks Schedule II through V controlled substances. Naltrexone is unscheduled, so LDN prescriptions do not appear in the PDMP and do not require a PDMP check before prescribing. This simplifies the prescribing process compared to controlled medications.

Georgia does not require a specific license or certification for providers to prescribe off-label medications. MDs, DOs, NPs (with appropriate collaborative agreements), and PAs licensed in Georgia can all prescribe LDN. Nurse practitioners in Georgia practice under a protocol agreement with a collaborating physician, per O.C.G.A. § 43-34-25, and the collaborating physician's scope determines whether NP-prescribed LDN is within the practice agreement.

For patients using compounding pharmacies outside of Georgia, prescribers should verify that the receiving pharmacy holds an active 503A license and is authorized to ship into the state. The Georgia Board of Pharmacy's online license verification tool can confirm in-state pharmacy status. Out-of-state pharmacies should be verified through their home state's board.

Standard starting dose is 1.5 mg nightly, titrated to 4.5 mg over 2 to 4 weeks 10. Patients should take LDN at bedtime because the transient opioid receptor blockade occurs during sleep, minimizing any potential for daytime side effects. The most common side effects reported in trials are vivid dreams (37%), headache (14%), and nausea (10%), all of which typically resolve within the first 2 weeks of treatment 3.

Patients currently taking opioid medications should not start LDN. Naltrexone, even at low doses, can precipitate acute opioid withdrawal. A minimum 7-day washout from short-acting opioids (or 14 days from long-acting opioids) is standard practice before initiating LDN therapy 1.